Cliff Belliveau, Chief Innovation Officer at MyMatrixx by Evernorth, has made it his business to understand what's happening beneath the AI marketing surface — and what he finds consistently surprises him.
"The confidence people feel is largely fueled by the B2C side of AI," Belliveau said referring to tools like ChatGPT or Gemini that anyone can pick up and use. But the consumer familiarity with those tools does not equal a competency or readiness for using AI to make high-stakes decisions about pharmacy recommendations, claims management, and patient safety.
“We hear about this every day,” said Paul King, President of MyMatrixx by Evernorth. “The industry is being influenced by buzzwords and promises of AI solutions to simplify claim management processes. But AI is not simple. There is a real gap between talking about AI and implementing an AI solution,” King continued.
For workers' comp carriers and employers, that gap between perceived AI understanding and actual governance isn't just an efficiency concern. It's a risk management problem.
In this Risk & Insurance article, Belliveau and King review critical questions to ask to help separate genuine AI solutions from impressive-sounding marketing claims. They also describe the distinction between generative and non-generative AI and what MyMatrixx is using for pharmacy and therapeutic recommendations, and they review the real costs of AI adoption.